Silexion Therapeutics (NASDAQ:SLXN) Price Target Cut to $5.00 by Analysts at Maxim Group
Silexion Therapeutics (NASDAQ:SLXN – Get Free Report) had its price target cut by investment analysts at Maxim Group from $9.00 to $5.00 in a report issued on Thursday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Maxim Group’s price target suggests a potential upside of 338.60% from the company’s previous close. Silexion […]
Silexion Therapeutics (NASDAQ:SLXN – Get Free Report) had its price target cut by investment analysts at Maxim Group from $9.00 to $5.00 in a report issued on Thursday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Maxim Group’s price target suggests a potential upside of 338.60% from the company’s previous close. Silexion […]
